NCT03115671View on ClinicalTrials.gov

Efficacy Study of Vayarin in Children With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Autism Spectrum DisorderAttention Deficit Hyperactivity Disorder

Interventions

DIETARY_SUPPLEMENT

Vayarin

Vayarin capsule

Trial Locations (1)

168937

Child Guidance Clinic, Singapore

All Listed Sponsors

lead

Institute of Mental Health, Singapore

OTHER

NCT03115671 - Efficacy Study of Vayarin in Children With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD) | Biotech Hunter | Biotech Hunter